Abstract:BACKGROUND:Cordyceps has long been used to treat cancer. However, its pharmacologically active components as well as the molecular mechanisms underlying its effects are still unclear.PURPOSE:To investigate the effect of MHP-1, a newly isolated polysaccharide from Mortierella hepialid (the asexual structure of C. sinensis), on breast cancer metastasis.STUDY DESIGN:The effect of MHP-1 on breast cancer cell migration, epithelial-mesenchymal transition (EMT) and TGF-β signaling were investigated in vitro and in vivo. The effect of MHP-1 against topotecan-resistant MCF-7 cells that developed an EMT-like phenotype was also examined.METHODS:The in vitro effect of MHP-1 on breast cancer cell proliferation and migration was evaluated by CCK8 and transwell assay. Morphological changes were observed and EMT markers were detected by western blot. The production of MMPs was measured by quantitative PCR and ELISA assay. To further investigate the mechanism that MHP-1 inhibited breast cancer EMT, western blot, ELISA, luciferase reporter gene assay, siRNA, quantitative PCR, immunohistochemistry, and xenograft tumor model were performed.RESULTS:MHP-1 inhibited breast cancer cell migration but did not cause any cytotoxicity. MHP-1 significantly surpressed breast cancer EMT, and slightly decreased MMP-9 secretion. TGF-β signaling was selectively inhibited after MHP-1 treatment, and other EMT-related pathways, like Wnt and Notch, were not affected. MHP-1 reduced the secretion of TGF-β1, but rarely affected other EMT-induced cytokines. Dual luciferase assay and Smad2/3 phosphorylation analysis indicated that MHP-1 suppressed TGF-β signaling. We further showed that MHP-1 restored sensitivity in topotecan (TPT)-resistant MCF-7 cells that developed an EMT-like phenotype. Similarly, the effect of TPT on resistant MCF-7 cells was also increased either by ALK5 (TGFβRI) siRNA or by a small molecular inhibitor of ALK5, SB-431542. MHP-1 inhibited breast cancer metastasis in the MDA-MB-231 xenograft model, and the immunohistochemical staining showed dramatically decreased expression of ALK5 and vimentin, and increased expression of E-cadherin.CONCLUSION:MHP-1 significantly inhibited breast cancer metastasis and restored drug sensitivity in TPT-resistant cells via down-regulation of TGF-β signaling and EMT program. The combination of non-toxic agents like MHP-1 and current anti-cancer drugs should be considered in the future treatment of cancer.

Tetramethypyrazine inhibits renal cell carcinoma cells through inhibition of NKG2D signaling pathways

Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression.

Inhibition of Cyclooxygenase-2 by Tetramethylpyrazine and Its Effects on A549 Cell Invasion and Metastasis

Tetrandrine Inhibits Migration And Invasion Of Human Renal Cell Carcinoma By Regulating Akt/Nf-Kappa B/Mmp-9 Signaling

Tetramethylpyrazine (TMP) Protects Cerebral Neurocytes and Inhibits Glioma by Down Regulating Chemokine Receptor CXCR4 Expression.

INHIBITORY EFFECT OF TETRAMETHYLPYRAZINE ON HEPATOCELLULAR CARCINOMA: POSSIBLE ROLE OF APOPTOSIS AND CELL CYCLE ARREST.

Tetramethylpyrazine (TMPZ) Triggers S-phase Arrest and Mitochondria-Dependent Apoptosis in Lung Cancer Cells

Inhibition Of Angiogenesis, Fibrosis And Thrombosis By Tetramethylpyrazine: Mechanisms Contributing To The Sdf-1/Cxcr4 Axis

Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)/combretastatin A4/BLZ945 nanoparticles on Renca renal carcinoma

Tetramethylpyrazine-mediated Regulation of CXCR4 in Retinoblastoma is Sensitive to Cell Density

Tetramethylpyrazine Reverses Multidrug Resistance in Breast Cancer Cells Through Regulating the Expression and Function of P-glycoprotein

Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer

Tetramethylpyrazine Downregulates Transcription of the CXC Receptor 4 (CXCR4) Via Nuclear Respiratory Factor‑1 (nrf‑1) in WERI‑Rb1 Retinoblastoma Cells.

Tetrandrine Suppresses Adhesion, Migration and Invasion of Human Colon Cancer SW620 Cells Via Inhibition of Nuclear Factor-Κb, Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Signaling Pathways

Tetramethylpyrazine Inhibits the Proliferation of Acute Lymphocytic Leukemia Cell Lines Via Decrease in GSK-3β.

Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway

Tetramethylpyrazine-Rhein Derivative Inhibits the Migration of Canine Inflammatory Mammary Carcinoma Cells by Mitochondrial Damage-Mediated Apoptosis and Cadherins Downregulation

MHP-1 Inhibits Cancer Metastasis and Restores Topotecan Sensitivity Via Regulating Epithelial-Mesenchymal Transition and TGF-β Signaling in Human Breast Cancer Cells.

Role of the ROS/AMPK Signaling Pathway in Tetramethylpyrazine-Induced Apoptosis in Gastric Cancer Cells.

NKG2D Immunoligand Rg7s-Mica Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines